|
| Model | OR | 95% CI | p-value |
|
| Subject Type |
|
|
|
| The researcher is trustworthy | Control vs Case | 1.46 | 0.72, 2.96 | 0.30 |
|
| Relative vs Case | 0.97 | 0.35, 2.63 | 0.95 |
|
| Gender | 2.00 | 1.03, 3.90 | 0.04 |
|
| Cancer at baseline | 1.01 | 0.52, 1.95 | 0.99 |
|
| Cancer at survey | 0.93 | 0.48, 1.83 | 0.84 |
|
| Stage of cancer | 0.35 | 0.04, 3.08 | 0.34 |
| The institution where the research is being conducted is trustworthy | Subject Type |
|
|
|
|
| Control vs Case | 0.94 | 0.44, 1.99 | 0.86 |
|
| Relative vs Case | 0.75 | 0.26, 2.17 | 0.60 |
|
| Gender | 1.61 | 0.79, 3.27 | 0.19 |
|
| Cancer at baseline | 1.39 | 0.69, 2.82 | 0.40 |
|
| Cancer at survey | 1.37 | 0.66, 2.84 | 0.40 |
|
| Stage of cancer | 0.31 | 0.04, 2.71 | 0.30 |
| I will receive a personal report about my individual genetic risks and/or benefits | Subject Type |
|
|
|
|
| Control vs Case | 1.92 | 1.27, 2.90 | 0.002 |
|
| Relative vs Case | 1.25 | 0.69, 2.25 | 0.46 |
|
| Gender | 1.15 | 0.77, 1.72 | 0.49 |
|
| Cancer at baseline | 0.54 | 0.37, 0.80 | 0.002 |
|
| Cancer at survey | 0.61 | 0.41, 0.90 | 0.01 |
|
| Stage of cancer | 0.58 | 0.19, 1.74 | 0.33 |
| Data and samples are stored securely | Subject Type |
|
|
|
|
| Control vs Case | 1.24 | 0.72, 2.16 | 0.44 |
|
| Relative vs Case | 0.78 | 0.33, 1.82 | 0.56 |
|
| Gender | 1.60 | 0.94, 2.73 | 0.08 |
|
| Cancer at baseline | 0.94 | 0.55, 1.58 | 0.80 |
|
| Cancer at survey | 0.95 | 0.55, 1.62 | 0.85 |
|
| Stage of cancer | N/A* | ||